Statins are one of the most widely used drugs worldwide as first-line drugs for the treatment of hyperlipidemia and the prevention and treatment of cardiovascular diseases. Most of the side effects of statins are known to be mild, and mainly hepatotoxicity and various muscle symptoms are known. Recently, there have been studies on concerns about an increase in the incidence of diabetes after using statins, but it was found that the benefits sufficiently outweigh the risk of side effects. Therefore, the use of statins in the appropriate group should be actively performed, and it seems that the side effects can be prevented through close physical observation and appropriate examination.
Citations
Citations to this article as recorded by
Policosanol (Reduchole22®) improves lipid profiles in HepG2 hepatocytes and Caco-2 enterocytes Soo-Hyeon Heo, Seul A Seo, KG Dinesh Yadav, Vadiraj Gururaj Bharadwaj, Srilakshmi Aluri, Sang Hyun Park, Hee-Young Ahn, Seong-Min Hong, Hyun-Dong Cho Food Science and Preservation.2025; 32(3): 498. CrossRef
Plant-derived HMG-CoA reductase inhibitor: computational and experimental insights for cardiovascular disease management Rahul Singh, Bhanu Sharma, Rituraj Purohit Journal of Molecular Liquids.2025; 439: 128792. CrossRef
Efficacy, side effects, adherence, affordability, and procurement of dietary supplements for treating hypercholesterolemia: a narrative review Isabel von Känel-Cordoba, Katharina Wirnitzer, Katja Weiss, Pantelis T. Nikolaidis, Asli Devrim-Lanpir, Lee Hill, Thomas Rosemann, Beat Knechtle Journal of Health, Population and Nutrition.2024;[Epub] CrossRef
The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients Roxana Nartea, Brindusa Ilinca Mitoiu, Ioana Ghiorghiu Current Issues in Molecular Biology.2023; 45(4): 3146. CrossRef
The effects of L-carnitine in reducing hepatotoxicity of statins in rats Doaa Ibrahim, Shahad Bader, Omar Bader Medicinski casopis.2023; 57(3): 59. CrossRef